Early infusion of recombinant human activated protein C decreases the number of years lost due to premature death

Autor:	L De la Cruz Avila, J Gutierrez Ruiz, AP Arriaga, E Quintero Zepeda, G Vazquez de Anda, C Zuniga Velazquez
Rok vydání:	2008
Předmět:	Premature death Recombinant human activated protein C business.industry Poster Presentation Medicine Critical Care and Intensive Care Medicine business Bioinformatics Severe sepsis
Zdroj:	Critical Care
ISSN:	1364-8535
DOI:	10.1186/cc6425
Popis:	Multicentre studies have demonstrated that early infusion of recombinant human activated protein C (rhAPC) improves survival of patients suffering from severe sepsis. The objective of this study was to demonstrate the benefit of early infusion of rhAPC on the number of years lost due to premature death (YLPD).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704658c1dcae3b27f01af1d26195b688 https://doi.org/10.1186/cc6425 Zobrazit plný text záznamu Full text from SpringerLink